Kim Theilgaard-Mønch

Kim Theilgaard-Mønch

Clinical Associate Professor, Group leader

Member of:

    ORCID: 0000-0002-4239-4939

    Publication year:
    All
    1 - 2 out of 2Page size: 10
    1. 2024
    2. Published

      Dose-reduction trials in oncology — aiming for less toxicity and better quality of life at lower costs

      Theilgaard-Mønch, Kim & Ehlers, L. H., 2024, In: Nature Reviews Clinical Oncology. 21, p. 81-82

      Research output: Contribution to journal › Comment/debate › Research

    3. Submitted

      Therapeutic inhibition of DNA-Damage Response and PI3K/AKT signaling in Acute Myleoid Leukemia: A novel therapeutic strategy to boost chemotherapy response and overcome resistance

      Theilgaard-Mønch, Kim, 2024, (Submitted) In: J Cell Immunol.

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 3997971